Jimlani, Aljimar A.

HRN: 22-17-17  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2022
CEFTRIAXONE 1G (VIAL)
11/04/2022
11/10/2022
IV DRIP
1.5 Grams
Q24
UTI, Leukocytosis
Waiting Final Action 
11/05/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/05/2022
11/12/2022
IV
300mg
Q8
Giardiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: